# Investigating the Safety of LEO 158968 in Healthy Volunteers

> **NCT05682352** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 120 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LEO 158968
- **DRUG:** Placebo
- **DRUG:** LEO 158968
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05682352
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-07
- **Primary completion:** 2024-05-07
- **Final completion:** 2024-08-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05682352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05682352, "Investigating the Safety of LEO 158968 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05682352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*